← All organizations

PLx Pharma

For profitWebsite ↗

Also known as: PLx Pharma | PLX PHARMA | PLx Pharma Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Apr 28, 2021

Timeline

2000s

Jun 1, 2002
PLx Pharma— Founded

2010s

Jan 14, 2013
acetylsalicylic acid— NDA Secondary Org
Dec 22, 2016
Dipexium Pharmaceuticals, Inc.— Acquired

Drugs by trial phase (4 distinct, 13 trials)

Phase 4 (1 own, 0 via acquisition)

acetylsalicylic acid

Phase 3 (0 own, 1 via acquisition)

pexiganan acetate

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

acetylsalicylic acid

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Dipexium Pharmaceuticals, Inc.

Recent trials (14)

NCT04811625Lead sponsorPhase 4Apr 28, 2021
NCT05055752Lead sponsorPhase 1May 7, 2020
NCT02008942Lead sponsorPhase 3Jan 1, 2014
NCT01646814Lead sponsorPhase 2Sep 1, 2012
NCT01515657Lead sponsorPhase 3Jan 1, 2012
NCT01244100Lead sponsorPhase 1Oct 1, 2010
NCT01244100Study directorPhase 1Oct 1, 2010
NCT01139190Lead sponsorPhase 2Jul 1, 2010
NCT00966641Overall official - principal investigatorPhase 1/Phase 2Aug 1, 2009
NCT00966641Lead sponsorPhase 1/Phase 2Aug 1, 2009
NCT00872534Lead sponsorPhase 1/Phase 2Jan 1, 2009
NCT04008979Lead sponsorPhase 1Feb 11, 2008
NCT04008979Study directorPhase 1Feb 11, 2008
NCT00219700Lead sponsorPhase 2Jan 1, 2005

Details

Founded: Houston, TX, US Jun 1, 2002
Last known activity: Apr 28, 2021